Expression of secretory phospholipase A2s in human atherosclerosis development |
| |
Authors: | Kimura-Matsumoto Masayo Ishikawa Yukio Komiyama Kazuo Tsuruta Tadashi Murakami Makoto Masuda Seiko Akasaka Yoshikiyo Ito Kinji Ishiguro Shigeki Morita Hiroshi Sato Shinji Ishii Toshiharu |
| |
Institution: | Department of Pathology, Toho University, School of Medicine, 5-21-16 Ohmori-nishi, Ohta-ku, Tokyo 143-8540, Japan. m-kimura@med.toho-u.ac.jp |
| |
Abstract: | Secretory phospholipase A2s (sPLA2s) contribute to the hydrolysis of phospholipid. Among them, sPLA2-IIA, -V, and -X have been regarded as enhancers of lipid accumulation in arterial intima. However, the distribution and production of the other types of sPLA2 in human aortic wall remain unclear. Therefore, in this study, the distribution and production of seven types of sPLA2 including IIA, IID, IIE, IIF, III, V, and X in atherosclerosis development in the human aorta were comprehensively examined by immunohistochemistry and in situ hybridization (ISH). The extent of sPLA2s expression increased with atherosclerosis development, but only sPLA2-IIF was never observed in the normal aorta. Double-immunostaining demonstrated that sPLA2-V expression was limited to smooth muscle cells (SMCs), although the other sPLA2s were expressed in both macrophages and SMCs. ISH using sPLA2 cDNAs revealed that the expression pattern of each mRNA was consistent with the results of immunohistochemistry for each corresponding sPLA2. These results indicate that the seven types of sPLA2 are expressed with various patterns in all stages of atherosclerosis development and may play an atherogenic role through degradation of phospholipid. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|